Intracoronary versus Intravenous Administration of Abciximab in Patients with Acute Coronary Syndrome: A Meta-Analysis

BACKGROUND: Abciximab is a widely used adjunctive therapy for acute coronary syndrome (ACS). However, the effect of intracoronary (IC) administration of abciximab on cardiovascular events remains unclear when compared with intravenous (IV) therapy. METHODOLOGY AND PRINCIPAL FINDINGS: We systematical...

Descripción completa

Detalles Bibliográficos
Autores principales: Wang, Jie-Ning, Diao, Shu, Tang, Yuan-Jun, Hou, An-Ji, Yuan, Hai-Bo, Zheng, Yan, Zhou, Yu-Hao
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Public Library of Science 2013
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3585408/
https://www.ncbi.nlm.nih.gov/pubmed/23469144
http://dx.doi.org/10.1371/journal.pone.0058077

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3585408/
https://www.ncbi.nlm.nih.gov/pubmed/23469144
http://dx.doi.org/10.1371/journal.pone.0058077

Ejemplares similares